Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
09/1993
09/15/1993EP0559893A1 Xanthine derivative
09/15/1993EP0559845A1 Use of compounds in preventing endotoxin shock
09/14/1993US5244906 Miticides for rice
09/14/1993US5244896 Carbocyclic adenosine analogs useful as immunosuppressants
09/14/1993US5244487 Adenine derivatives and their use as agents for increasing yield of crops
09/14/1993CA1322195C Acetylenic, cyano and allenic aristeromycin/adenosine derivatives
09/13/1993CA2091553A1 Xanthine derivatives
09/13/1993CA2091415A1 Substituted benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
09/08/1993EP0558659A1 Tnf inhibitors
09/02/1993WO1993017035A1 2'ISODIDEOXY-β-D-NUCLEOSIDES AS STABLE ANTIVIRAL AGENTS
09/02/1993WO1993017021A1 Heterocyclic compounds for enhancing antitumor activity
09/02/1993WO1993017020A2 Therapeutic nucleosides
09/02/1993CA2129337A1 Heterocyclic compounds for enhancing antitumor activity
09/01/1993EP0557876A1 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation
08/1993
08/31/1993US5241069 Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
08/25/1993EP0556778A2 Xanthine derivatives
08/25/1993EP0249610B1 Synthesis of optically active aryloxypropanolamines and arylethanolamines
08/23/1993CA2089959A1 Use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation
08/18/1993CN1021820C Process for n-substituted adenine and n'-substituted cytimidine
08/17/1993US5237096 Racemization of (1S-trans)-3-methylenecyclopropane-1,2-dicarboxylic acid; salt formation, acidification, extraction
08/17/1993US5237095 Process for the preparation of an antiviral agent
08/11/1993EP0554274A1 Nucleoside derivatives
08/10/1993US5235052 Reacting a ketene thioacetal with an enantiomerically pure diester of fumaric acid in the presence of a Lewis Acid to produce a pure trans cyclobutane compound
08/10/1993US5235045 Viricides
08/10/1993CA1321145C Pharmaceutical preparations
08/10/1993CA1321144C Pharmaceutical preparations
08/10/1993CA1321101C Device for continuously decaffeinating raw coffee
08/05/1993WO1993015075A1 Preparation of 2-amino-6-chloropurine
08/05/1993CA2117435A1 Preparation of 2-amino-6-chloropurine
08/04/1993EP0554025A2 Fluorinated cyclobutyl purines and pyrimidines
08/03/1993US5233086 Intermediates for the preparation of an antiviral agent
08/03/1993US5233041 Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
07/1993
07/28/1993EP0552712A1 8-(1-Aminocycloalkyl)-1,3-dialkylxanthine derivatives as antagonists adenosine receptors
07/28/1993CA2088196A1 Fluorinated cyclobutyl purines and pyrimidines
07/27/1993US5231174 2'isodideoxy-β-D-nucleosides as stable antiviral agents
07/24/1993WO1993014636A1 Insect control with substituted oxadiazole and thiadiazole compounds
07/24/1993CA2105556A1 Insect control with substituted oxadiazole and thiadiazole compounds
07/22/1993WO1993014069A1 Heterocyclic sulfonamide derivatives as antagonists of paf and angiotensin ii
07/22/1993CA2127367A1 Heterocyclic sulfonamide derivatives as antagonists of paf and angiotensin ii
07/14/1993EP0550574A1 Heterocyclic compounds
07/14/1993EP0550570A1 Xanthine derivatives
07/14/1993EP0550559A1 Xanthines
07/13/1993CA1320196C Immunostimulating guanine derivatives, compositions and methods
07/13/1993CA1320195C Adenosine derivatives
07/07/1993CN1073861A Medicinal composite to improve dysuria
07/06/1993US5225590 Intermediates for viricide, reaction of anhydride and glycerol derivative
07/06/1993US5225550 Process for the preparation of substituted acyclic nucleosides, and intermediates occurring therein
07/06/1993US5225414 Substituted azoles, a process for their preparation, and their use
07/01/1993DE4143267A1 3-Methyl- and 1,3-di:methyl-4-amino-5-formyl:amino-uracil prodn. - by treating crude mixt. contg. 3-methyl- or 1,3-di:methyl-4,5-di:amino-uracil with sulphur di:oxide and reacting with formic acid
06/1993
06/30/1993EP0548798A1 Antiviral agent
06/30/1993EP0548640A2 Process for the preparation of 2,4,5-triamino-6-halopyrimidines and 2-amino-6-halopurines
06/29/1993US5223619 Catalytic cyclization
06/29/1993US5223504 Xanthine compounds and compositions, and methods of using them
06/29/1993US5223501 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
06/29/1993US5223499 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
06/23/1993EP0547508A1 Use of xanthine derivatives for the stabilisation of the auto-regulation of cerebral blood flow
06/22/1993CA1319321C Pharmaceutical preparations
06/16/1993EP0546547A1 Pharmaceutical composition for the improvement of dysuria
06/16/1993CN2136244Y Apparatus for extracting natural caffeine directly from tea
06/15/1993US5220024 Process for the preparation of purine derivatives as antiviral agents
06/15/1993US5220003 Process for the synthesis of 2',3'-dideoxynucleosides
06/12/1993CA2085046A1 Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation
06/11/1993CA2084962A1 Pharmaceutical composition for the improvement of dysuria
06/10/1993WO1993011106A1 Indole derivatives
06/09/1993EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants
06/09/1993EP0544668A1 -6-fluoro-9-(2,3-dideoxy-b-d-glycero-pentofuranosyl)-9h-purines and their use asantiviral agents
06/09/1993EP0487657A4 Process for the synthesis of cyclopentene derivatives
06/08/1993US5218142 Recovering racemic (trans) 3-methylene-1,2-cyclopropanedicarboxylic acid from the reaction of (trans)-3-methylene-1,2-cyclopropanedicarboxylic acid with (r)-(+)-alpha -methylbenzylamine
06/08/1993US5217982 Compounds having antihypertensive properties
06/08/1993US5217980 Oxazolyl and piperidinyl substituted benimidazolyl compounds
06/08/1993CA1318850C Pharmaceutical products
06/08/1993CA1318811C Process for decaffeinating green coffee
06/02/1993EP0544445A2 Furyl-substituted purines, oxazolopyrimidines and pteridines as adenosine antagonists
06/02/1993EP0544391A1 Compositions for topical treatment of psoriasis and atopic dermatitis
06/02/1993CN1072680A Optically active azole compounds, their production and use
06/02/1993CN1072679A 吲哚衍生物 Indole derivatives
06/01/1993US5216183 Antitumor, anticarcinogenic agents; bone formation accelerators
06/01/1993US5216142 Anti-virals
06/01/1993US5216141 Oligonucleotide analogs containing sulfur linkages
06/01/1993US5215987 Carbdiotonic agents
06/01/1993CA1318666C Immunostimulating guanine derivatives, compositions and methods
05/1993
05/27/1993WO1993010097A1 Nitro compounds having vasodilator activity
05/27/1993CA2123569A1 Nitro compounds having vasodilator activity
05/26/1993EP0543491A2 Angiotensin II antagonists having a substituted 1,3-benzodioxolering or 1,3-benzodithiolering
05/26/1993EP0543245A1 Renin inhibiting amino acid derivatives
05/26/1993EP0543095A2 Method for producing 2-amino-6-halogenopurine and synthesis intermediate therefor
05/26/1993CN1072413A 氨基酸衍生物 Amino acid derivatives
05/26/1993CN1020906C Process for preparation of 2-(heterocyclylalkyl) imidazopyridines compounds
05/26/1993CA2082333A1 Heterocyclic compounds
05/25/1993US5214048 Oxetanocins
05/25/1993CA1318316C Fungicides
05/20/1993CA2081236A1 Amino acid derivatives
05/19/1993EP0542681A1 Process for the preparation of carbocyclic nucleosides and its intermediates
05/19/1993EP0542680A1 Protected formylpentanediols and protected hydroxymethylpentanediols, process for their preparation and intermediates
05/18/1993US5211738 Adenine derivatives and their use as a plant growth regulator
05/18/1993CA1317941C Piperidine derivative and pharmaceutical composition containing the same
05/18/1993CA1317939C ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
05/13/1993CA2082552A1 Process for the preparation of carbacyclic nucleosides, and intermediates
05/13/1993CA2082546A1 Protected formylpentanediols, hydroxymethylpentanediols, process for their preparation, and intermediates
05/12/1993EP0541120A2 Xanthine derivatives for the treatment of dementia